Giuseppe Marrone
Overview
Explore the profile of Giuseppe Marrone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
390
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Spoletini G, Mauro A, Caimano M, Marrone G, Frongillo F, Agnes S, et al.
Cancers (Basel)
. 2025 Jan;
16(24.
PMID: 39766064
: Lymphadenectomy in the operative management of hepatocellular carcinoma (HCC) remains controversial, with no recommendation for routine practice. Our study aimed to assess the effects of lymphadenectomy in addition to...
2.
Pagano D, Toniutto P, Burra P, Gruttadauria S, Vella R, Martini S, et al.
Dig Liver Dis
. 2024 Dec;
PMID: 39645428
Hypoalbuminemia is a risk factor for mortality in patients with end-stage liver disease (ESLD) and in those undergoing orthotopic liver transplantation (OLT), since it represents a biomarker of post-operative delayed...
3.
Biolato M, Miele L, Marrone G, Tarli C, Liguori A, Calia R, et al.
World J Transplant
. 2024 Jul;
14(2):92376.
PMID: 38947971
Background: Few studies have evaluated the frequency of and the reasons behind the refusal of listing liver transplantation candidates. Aim: To assess the ineligibility rate for liver transplantation and its...
4.
Biolato M, Terranova R, Viceconti N, Marrone G, Miele L, Giustiniani M, et al.
Gastroenterol Rep (Oxf)
. 2024 Apr;
12:goae022.
PMID: 38665279
No abstract available.
5.
Lai Q, Caimano M, Canale F, Birtolo L, Ferri F, Ginanni Corradini S, et al.
Transplant Rev (Orlando)
. 2024 Feb;
38(2):100838.
PMID: 38417399
Background & Aims: Echocardiographic findings may provide valuable information about the cardiac conditions in cirrhotic patients waiting for liver transplantation (LT). However, data on the ability of the different echocardiographic...
6.
Marrone G, Leone M, Biolato M, Liguori A, Bianco G, Spoletini G, et al.
Cancers (Basel)
. 2023 Dec;
15(23).
PMID: 38067299
Hepatocellular carcinoma (HCC) is a growing indication for liver transplantation (LT). Careful candidate selection is a prerequisite to keep post-LT recurrence rates within acceptable percentages. In the pre-LT period, various...
7.
Caimano M, Bianco G, Coppola A, Marrone G, Agnes S, Lai Q, et al.
Int J Surg
. 2023 Oct;
110(1):431-440.
PMID: 37800567
Background: Liver transplantation (LT) is the gold standard for end-stage liver disease, yet postoperative complications challenge patients and physicians. Indocyanine green (ICG) clearance, a quantitative dynamic test of liver function,...
8.
Marrone G, Giannelli V, Agnes S, Avolio A, Baiocchi L, Berardi G, et al.
Liver Int
. 2023 Sep;
44(1):103-112.
PMID: 37752798
Background And Aims: Model for End-stage Liver Disease (MELD) and MELDNa are used worldwide to guide graft allocation in liver transplantation (LT). Evidence exists that females are penalized in the...
9.
Marrone G, Covino M, Merra G, Piccioni A, Amodeo A, Novelli A, et al.
Liver Int
. 2023 Sep;
44(1):83-92.
PMID: 37735968
Background: Ursodeoxycholic acid (UDCA) has been recently proposed as a modulator of angiotensin-converting enzyme 2 (ACE2) receptor expression, with potential effects on COVID-19. Aim And Study Design: We retrospectively evaluated...
10.
Lai Q, Lenci I, Giannelli V, Marrone G
Liver Int
. 2023 Sep;
43(10):2332-2333.
PMID: 37665132
No abstract available.